PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 1 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42 | +55.6% | 13,316 | +120.0% | 0.00% | – |
| Q2 2023 | $27 | -54.2% | 6,052 | -41.4% | 0.00% | – |
| Q1 2023 | $59 | -89.3% | 10,322 | -88.6% | 0.00% | – |
| Q4 2022 | $549 | -98.4% | 90,824 | +1657.4% | 0.00% | – |
| Q3 2022 | $34,000 | +61.9% | 5,168 | +27.3% | 0.00% | – |
| Q2 2022 | $21,000 | -47.5% | 4,060 | -30.9% | 0.00% | – |
| Q1 2022 | $40,000 | – | 5,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $287,436,000 | 2.91% |
| Baker Brothers Advisors | 10,123,824 | $289,845,000 | 1.27% |
| Logos Global Management LP | 400,000 | $11,452,000 | 0.96% |
| Rock Springs Capital Management LP | 382,359 | $10,947,000 | 0.22% |
| HHLR ADVISORS, LTD. | 583,333 | $16,701,000 | 0.17% |
| Virtus ETF Advisers LLC | 6,622 | $190,000 | 0.08% |
| Jump Financial, LLC | 13,700 | $392,000 | 0.04% |
| ARS Investment Partners, LLC | 7,400 | $212,000 | 0.02% |
| FEDERATED HERMES, INC. | 336,100 | $9,623,000 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 1,287,735 | $36,867,853,000 | 0.02% |